Call for papers: Connective tissue disease-associated interstitial lung disease
Published in Healthcare & Nursing and General & Internal Medicine
BMC Pulmonary Medicine is calling for submissions to our Collection on connective tissue disease-associated interstitial lung disease.
Interstitial Lung Disease (ILD) is a common manifestation of several systemic autoimmune connective tissue diseases (CTDs). While ILD can manifest with all CTDs, it most commonly affects individuals with rheumatoid arthritis (RA, 10-30%), systemic sclerosis (SSc, 40-80%), and idiopathic inflammatory myopathy (IIM, 40%). In some patients, ILD could also be the initial or only manifestation of an underlying CTD and the research classification “interstitial pneumonia with autoimmune features (IPAF)” was recently proposed to identify these patients. ILD poses a significant burden, contributing to morbidity and mortality among CTD patients. Given the complexity in the diagnosis and treatment of CTD-related ILD, a multidisciplinary approach to management is crucial.
Over the years, advances in research have improved our understanding and management of CTD-related ILD. However, there are still significant gaps in our knowledge. With the emergence of new therapies for this patient population, there is an increased need to identify clinical characteristics and biomarkers that could predict those who are likely to develop ILD and/or have progressive disease. There is also a continued need to understand additional mechanistic pathways that lead to ILD, in order to develop novel therapies.
For this research topic collection, BMC Pulmonary Medicine invites basic and clinical research papers that could enhance our understanding of CTD-associated ILD and contribute to the advancement of patient care.
Topics of interest for this Collection include but are not limited to:
• Mechanisms and genetics associated with CTD-ILD
• Epidemiology of CTD-ILD: prevalence, mortality, hospitalizations
• Early diagnosis, risk predictors and biomarkers that could predict development and prognosis of CTD-ILD
• Novel therapies for CTD-ILD
• Barriers/limitations to timely care
• Multidisciplinary approach to diagnosis and treatment, and other treatment models
Meet the Guest Editors
Bruno Guedes Baldi: University of Sao Paulo Medical School, Brazil
Dr Bruno Guedes Baldi is a Pulmonologist. He is the Medical Assistant of the Pulmonary Division, Heart Institute (InCor) at the University of Sao Paulo Medical School, Sao Paulo, Brazil. His expertise is in interstitial and rare lung diseases, with a hundred articles published. He has served as an editor, including Associate Editor of Frontiers in Medicine and BMC Pulmonary Medicine, as well as Editor-in-Chief of the Jornal Brasileiro de Pneumologia from 2019 to 2022
Niranjan Jeganathan: Loma Linda University Health System School of Medicine, US
Dr Niranjan Jeganathan is a pulmonologist with a special interest in interstitial lung diseases (ILD). He is the Director of the ILD Center at Loma Linda University (California) which is a Pulmonary Fibrosis Foundation Care Center. His research interest within ILD is in understanding the epidemiology of ILD including Connective Tissue Diseases-Related ILD. He has been an editor for other research collections related to ILD. In addition, he has reviewed numerous ILD articles for many different journals.
Jin Woo Song: University of Ulsan College of Medicine, South Korea
Dr Jin Woo Song is Professor in the Department of Pulmonary and Critical Care Medicine at the University of Ulsan College of Medicine, South Korea. He is currently Director of the ILD Program at Asan Medical Center in Seoul, South Korea. His academic interests include the effects of air pollution on clinical outcomes in ILD, metabolic changes in ILD and biomarkers in ILD.
Submission Guidelines
This Collection welcomes submission of original Research Articles. Should you wish to submit a different article type, please read our submission guidelines to confirm that type is accepted by the journal. Articles for this Collection should be submitted via our submission system, Snapp. During the submission process you will be asked whether you are submitting to a Collection, please select "Connective tissue disease-associated interstitial lung disease" from the dropdown menu.
Articles will undergo the journal’s standard peer-review process and are subject to all of the journal’s standard policies. Articles will be added to the Collection as they are published.
The Guest Editors have no competing interests with the submissions which they handle through the peer review process. The peer review of any submissions for which the Guest Editors have competing interests is handled by another Editorial Board Member who has no competing interests.
Submission Status: Open | Submission Deadline: 8 April 2024
Follow the Topic
-
BMC Pulmonary Medicine
This journal is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of pulmonary and associated disorders, as well as related molecular genetics, pathophysiology, and epidemiology.
Your space to connect: The Primary immunodeficiency disorders Hub
A new Communities’ space to connect, collaborate, and explore research on Clinical Medicine, Immunology, and Diseases!
Continue reading announcementRelated Collections
With Collections, you can get published faster and increase your visibility.
Social and economic factors in pulmonary disease and disorders
BMC Pulmonary Medicine is calling for submissions to our Collection on social and economic factors in pulmonary disease and disorders. Pulmonary diseases and disorders are increasingly recognized as not only medical conditions but also as complex issues deeply intertwined with social and economic factors. Conditions such as asthma, chronic obstructive pulmonary disease (COPD), and lung cancer disproportionately affect specific demographics, particularly those in low-income communities and vulnerable populations. Infectious diseases affecting the lungs are also a challenge for those living in cramped or overcrowded areas. This Collection aims to illuminate how socioeconomic status, environmental exposures, and other social determinants impact the prevalence, management, and outcomes of pulmonary diseases, fostering a more holistic understanding of these conditions.
Addressing the intersection of pulmonary diseases and socioeconomic factors is crucial for developing effective public health interventions and policies. Recent advancements in research have highlighted the critical role that exposure to environmental pollution, access to healthcare, and health literacy play in exacerbating lung disorders in marginalized groups. By identifying and understanding these interrelations, researchers and healthcare professionals can better advocate for equity in healthcare access and improve treatment outcomes for affected populations. With a focus on social determinants, there is potential to develop tailored interventions that not only target the diseases themselves but also the underlying social and economic factors that contribute to their prevalence. We invite submissions on a range of topics that include, but are not limited to:
- Social determinants of pulmonary health
- Biological mechanisms linking social factors and environmental exposure to lung disease
- Longitudinal or causal approaches to associating social factors and environmental exposure to lung disease
- Impact of environmental pollution on lung disease
- Pulmonary diseases and disorders in low-income communities
- Lines of work in resource-limited settings that contribute to pulmonary disease
- Health disparities in refugee and migrant populations
- Socioeconomic factors influencing treatment adherence
- Diagnosis and treatment options in resource-limited settings
This Collection supports and amplifies research related to SDG 1: No Poverty, SDG 3: Good Health and Well-being, SDG 8: Decent Work and Economic Growth, and SDG 11: Sustainable Cities and Communities.
All manuscripts submitted to this journal, including those submitted to collections and special issues, are assessed in line with our editorial policies and the journal’s peer review process. Reviewers and editors are required to declare competing interests and can be excluded from the peer review process if a competing interest exists.
Publishing Model: Open Access
Deadline: Feb 10, 2027
Please sign in or register for FREE
If you are a registered user on Research Communities by Springer Nature, please sign in